EMEA: Draft guideline on the clinical evaluation of anti-fungal agents for the treatment and prophylaxis invasive fungal disease
26.06.2009
The guideline is primarily concerned with the content of clinical development programmes to assess the safety and efficacy of antifungal agents administered by oral or parenteral routes for the treatment and prophylaxis of IFD.
The source of the news: http://www.emea.europa.eu/pdfs/human/ewp/134301endraft.pdf
SciencePharma
